How Do Certified Testosteronologists® Treat Patients? (TRT Q&As)
Timeline
Timestamp
Topic
00:20
How do Certified Testosteronologists® work, and will they follow Dr. O’Connor’s approach to treatment?
The member asks whether clinicians in the provider directory use Dr. O’Connor’s approach to testosterone care. Dr. O’Connor explains that these independent clinicians are trained directly through the Testosteronology Society®, participate in ongoing case discussions and education, and apply that training while making their own clinical decisions for individual patients.
The member asks whether clinicians in the provider directory use Dr. O’Connor’s approach to testosterone care. Dr. O’Connor explains that these independent clinicians are trained directly through the Testosteronology Society®, participate in ongoing case discussions and education, and apply that training while making their own clinical decisions for individual patients.
07:20
What should I do about a coronary calcium score of 1,571?
A 55-year-old member reports extensive coronary calcification involving multiple coronary arteries. Dr. O’Connor treats the finding as significant coronary atherosclerosis and works through family history, weight, blood pressure, glucose control, cholesterol, prior steroid exposure, and other cardiovascular risks while emphasizing aggressive medical management.
A 55-year-old member reports extensive coronary calcification involving multiple coronary arteries. Dr. O’Connor treats the finding as significant coronary atherosclerosis and works through family history, weight, blood pressure, glucose control, cholesterol, prior steroid exposure, and other cardiovascular risks while emphasizing aggressive medical management.
25:30
What should I do about a coronary calcium score of 1,571?
A 55-year-old member reports extensive coronary calcification involving multiple coronary arteries. Dr. O’Connor treats the finding as significant coronary atherosclerosis and works through family history, weight, blood pressure, glucose control, cholesterol, prior steroid exposure, and other cardiovascular risks while emphasizing aggressive medical management.
A 55-year-old member reports extensive coronary calcification involving multiple coronary arteries. Dr. O’Connor treats the finding as significant coronary atherosclerosis and works through family history, weight, blood pressure, glucose control, cholesterol, prior steroid exposure, and other cardiovascular risks while emphasizing aggressive medical management.
35:30
What should I do about a 4.5-centimeter ascending aortic dilation while I am on TRT?
A 32-year-old member describes an ascending aortic dilation discovered during cardiac imaging. Dr. O’Connor emphasizes specialist evaluation, particularly by an experienced cardiothoracic surgeon or cardiologist, along with careful blood pressure and heart-rate control and appropriate repeat imaging to monitor the aorta.
A 32-year-old member describes an ascending aortic dilation discovered during cardiac imaging. Dr. O’Connor emphasizes specialist evaluation, particularly by an experienced cardiothoracic surgeon or cardiologist, along with careful blood pressure and heart-rate control and appropriate repeat imaging to monitor the aorta.
50:50
What are the main side effects and health risks I should worry about from Anavar?
A 45-year-old member on TRT says he is approaching 12 weeks of Anavar and feels well but wants to understand the risks. Dr. O’Connor discusses potential effects on cholesterol, blood pressure, kidneys and proteinuria, liver markers, sexual function, and overall cardiovascular health despite Anavar’s reputation as a comparatively milder anabolic steroid.
A 45-year-old member on TRT says he is approaching 12 weeks of Anavar and feels well but wants to understand the risks. Dr. O’Connor discusses potential effects on cholesterol, blood pressure, kidneys and proteinuria, liver markers, sexual function, and overall cardiovascular health despite Anavar’s reputation as a comparatively milder anabolic steroid.
59:00
Can aggressive cholesterol treatment actually remove stable coronary plaque, or does it only stop the plaque from progressing?
Dr. O’Connor explains that aggressive medical management is primarily intended to stabilize atherosclerotic plaque and reduce the risk of rupture, heart attack, and stroke. He also discusses evidence that intensive lipid lowering can produce some plaque regression, while emphasizing that plaque stabilization itself is a major therapeutic benefit.
Dr. O’Connor explains that aggressive medical management is primarily intended to stabilize atherosclerotic plaque and reduce the risk of rupture, heart attack, and stroke. He also discusses evidence that intensive lipid lowering can produce some plaque regression, while emphasizing that plaque stabilization itself is a major therapeutic benefit.
Video Summary
This session addresses a range of questions that come up in real-world hormone and metabolic care. Rather than treating any single number as definitive, the discussion emphasizes lab-centered decision-making that integrates symptoms, history, and repeatable trends. Viewers get a clear sense of how clinicians prioritize stability and follow-up when uncertainty is high.
Several segments focus on how and when to adjust a plan, including dosing choices, monitoring cadence, and symptom tracking. The conversation highlights common misinterpretations that lead to unnecessary changes, and it explains what would justify reassessment. Practical framing is provided so patients can bring better questions to follow-up visits.
Risk and prevention themes also appear throughout, including cardiometabolic markers and long-term health planning. The session reinforces that individualized care depends on context, goals, and tolerability, not rigid rules. Overall, the episode provides a structured way to think about next steps without losing sight of long-term outcomes.
Drug Callouts
Drug
Description
Testosterone
Testosterone is an androgen hormone that supports sexual function, red blood cell production, bone density, and muscle mass. The session connects testosterone to clinical decision points such as reassessment intervals, expected response, and avoiding overreaction to isolated changes.
Metformin
Metformin is an antihyperglycemic medication used in type 2 diabetes that improves insulin sensitivity and reduces hepatic glucose production. The conversation references metformin while weighing practical next steps, follow-up timing, and what would trigger reconsideration.
Statins
Statins are lipid-lowering medications that reduce LDL cholesterol by inhibiting HMG‑CoA reductase in the liver. The Q&A touches on statin in the context of monitoring goals, symptom reports, and risk tradeoffs discussed during the session.
Condition Callouts
Condition
Description
Diabetes
Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia due to impaired insulin secretion, insulin action, or both. Diabetes is mentioned alongside related labs and symptoms, framing how clinicians think about decisions over time rather than single moments.
Hypertension
Hypertension is persistently elevated arterial blood pressure that increases the risk of cardiovascular, cerebrovascular, and renal disease. The Q&A touches on hypertension in the context of monitoring goals, symptom reports, and risk tradeoffs discussed during the session.
Key Takeaways
- Lab trends over time are more informative than single measurements when symptoms are stable.
- Reference ranges help, but decisions still depend on individual context and goals.
- Follow-up timing should be planned to answer a specific clinical question, not to chase reassurance.
- Clear symptom tracking makes lab interpretation more actionable and less reactive.
- Measured observation can be the safest choice when risk is low and uncertainty is high.